TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ProPharma Group Sweden AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
8,634
|
8,756
|
9,467 |
| Financial expenses |
130
|
1
|
27 |
| Earnings before taxes |
-330
|
-448
|
472 |
| EBITDA |
-383
|
-431
|
530 |
| Total assets |
5,999
|
4,727
|
4,390 |
| Current assets |
5,951
|
4,667
|
4,308 |
| Current liabilities |
4,003
|
2,408
|
1,380 |
| Equity capital |
1,758
|
2,022
|
2,606 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
57
|
65
|
57 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
29.3%
|
42.8%
|
59.4% |
| Turnover per employee |
151
|
135
|
166 |
| Profit as a percentage of turnover |
-3.8%
|
-5.1%
|
5.0% |
| Return on assets (ROA) |
-3.3%
|
-9.5%
|
11.4% |
| Current ratio |
148.7%
|
193.8%
|
312.2% |
| Return on equity (ROE) |
-18.8%
|
-22.2%
|
18.1% |
| Change turnover |
-148
|
57
|
-59 |
| Change turnover % |
-2%
|
1%
|
-1% |
| Chg. No. of employees |
-8
|
8
|
-5 |
| Chg. No. of employees % |
-12%
|
14%
|
-8% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.